Radical cyclization improves synthesis of antitumor 2-imino-2,5-dihydrofurans, suggesting drug development potential.
Isocyanide radical cyclization, typically restricted to aryl isocyanides, is hampered by complex radical precursors. We've developed a strategy that overcomes this constraint by integrating [4 + 1] cyclization with a multifunctional system, which extends to alkyl and biomolecule-derived isocyanides and achieves a rare 1,2,3,4-tetrasubstitution of α,β-unsaturated carbonyls. Over 50 2-imino-2,5-dihydrofuran derivatives have been synthesized, allowing for molecular skeleton editing into valuable frameworks. These derivatives show antitumor activity, indicating their potential in drug development.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: